Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

A promising therapeutic approach in amyotrophic lateral sclerosis (ALS)

Published on: 20/10/2020 Reading time: 1 min
image

Paris, October 19th, 2020 - ALS is characterized by the degeneration of motor neurons resulting in a progressive and irreversible deficit in walking and speech, until a complete paralysis of all muscles, including those controlling respiration. The team led by Séverine Boillée (Inserm researcher) at the Paris Brain Institute has just published work in the prestigious scientific journal Nature Neuroscience, paving the way to a new therapeutic approach for this still incurable disease.

Ten percent of ALS cases are familial, linked to mutations in genes, identified in 2/3 of cases. Experimental models (particularly in mice) in which the SOD1 gene is mutated,  reproduce the clinical phenotype of the disease in humans and are used to study biological mechanisms of the disease, but also give the opportunity to test the efficiency and harmlessness of new treatments before using them in patients for therapeutic trials.

Spinal motor neurons affected in ALS have the particularity of being surrounded both by microglial cells in the spinal cord and by peripheral macrophages in the nerve, which is the part of the motor neuron exiting from the spinal column to connect peripheral muscles.

Macrophages are the blood cells at the forefront of the immune response whose main role is to defend the body against infections but also to contribute to heal the injured tissue during damage. Microglial cells (or microglia) are a subgroup of macrophages located in the central nervous system (spinal cord and brain).

While the role of microglia in motor neuron degeneration in ALS is now recognized, the role of circulating macrophages in disease progression was still controversial mainly because previous studies focused on their infiltration into the central nervous system while their implication, from the periphery, in the nerves during the course of the disease had not been fully demonstrated.

The objective of the project led by Séverine Boillée's team was to show the involvement of these immune cells from the periphery since they would be more accessible in patients, in order to identify new therapeutic targets.

Using experimental mouse models and tissues of 11 patients suffering from ALS, the researchers were able to show for the first time:

  • The ability of peripheral macrophages to influence, from the periphery, microglial cell activation in the central nervous system and motor neurons degeneration, showing a delay in the symptomatic phase and an increase in lifespan in the mouse model.
image
  • Molecular profiles (transcriptomes) of microglial cells (in the spinal cord) and peripheral macrophages (in the sciatic nerve) are very different. This reflects the distinct response of these two cell types although closely related and reacting to the same event, the motor neuron death, and gives the possibility to identify new mechanisms to target for future therapies.

The authors of this work conclude for the first time that peripheral macrophages have an important role in the progression of amyotrophic lateral sclerosis (ALS), thus paving the way to new therapeutic strategies for patients.

In longer term, the development of research aiming at treating neurotoxic macrophages outside the central nervous system, i.e. in a less invasive manner could lead to a significant decrease in motor neuron death in ALS patients.

These results now constitute a promising treatment approach to be explored.

Sources

Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival.

Aude Chiot, Sakina Zaïdi, Charlène Iltis, Matthieu Ribon, Félix Berriat, Lorenzo Schiaffino, Ariane Jolly, Pierre de la Grange, Michel Mallat, Delphine Bohl, Stéphanie Millecamps, Danielle Seilhean, Christian S. Lobsiger and Séverine Boillée

NATURE NEUROSCIENCE. DOI : 10.1038/s41593-020-00718-z.

Our news on the subject

Le développement du cerveau a une part d’aléatoire
The stochastic aspect of brain development
Although every person’s personality is the result of genetic and environmental factors, these are not the only factors at play. Bassem Hassan and his team at Paris Brain Institute have discovered that, in fruit flies (drosophila), individuality also...
05.12.2025 Research, science & health
Analyse MERSCOPE
New treatment pathways for brain malformation-linked focal epilepsy?
A study by Stéphanie Baulac’s team has revealed somatic mutations in different cell types in patients with type 2 focal cortical dysplasia. This disease causes drug-resistant epileptic seizures, for which the main treatment option is currently...
05.12.2025 Research, science & health
Un iceberg
The ICEBERG cohort, 10 years of collective scientific and medical mobilization
The ICEBERG cohort, initiated 10 years ago, is interested in studying factors predictive of the onset and progression of Parkinson’s disease.
05.15.2025 Research, science & health
La huntingtine est une protéine indispensable au développement embryonnaire, à la formation et au maintien du tissu cérébral.
Huntington's Disease: The Energy Hypothesis Gets Traction
Huntington's disease, a rare hereditary neurological disorder, is associated with an energy deficit that precedes the onset of symptoms and is closely linked to their progression. At Paris Brain Institute, Fanny Mochel and her colleagues are testing...
02.11.2025 Research, science & health
À la recherche de marqueurs d’imagerie dans la démence frontotemporale
Searching for Imaging Markers in Frontotemporal Dementia
Could exploring the relationships between different brain networks help us understand frontotemporal dementia (FTD)? This neurodegenerative disease, which progresses at varying rates, is often diagnosed late—when clinical signs are already severe. At...
01.07.2025 Research, science & health
Monocyte – un globule blanc qui se différencie en macrophage. Crédit : Université d’Edinbourg.
Discovery of a Macrophage Anomaly in Multiple Sclerosis
Certain patients with multiple sclerosis (MS) can partially regenerate myelin—the protective sheath that surrounds nerve fibers—which is damaged during the evolution of the disease. In studying how immune cells influence this remyelination...
12.19.2024 Research, science & health
See all our news